Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vincerx Pharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VINC
Nasdaq
8731
https://vincerx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vincerx Pharma Inc
12 Most Profitable Biotech Stocks To Invest In
- Mar 14th, 2024 1:38 pm
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
- Mar 5th, 2024 9:31 pm
Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week
- Mar 5th, 2024 11:06 am
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
- Jan 7th, 2024 8:00 pm
15 Best Falling Stocks To Buy Now
- Dec 19th, 2023 4:07 pm
Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
- Dec 10th, 2023 5:00 pm
Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 14th, 2023 12:00 pm
Vincerx Pharma To Present Three Posters at ASH 2023 in December
- Nov 2nd, 2023 1:10 pm
New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network
- Oct 13th, 2023 1:12 pm
New to The Street Announces TV Corporate Appearances, Broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET
- Oct 6th, 2023 1:30 pm
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
- Sep 19th, 2023 11:00 am
Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943
- Sep 14th, 2023 11:00 am
Vincerx Pharma Announces FDA Clearance of IND for VIP943
- Aug 22nd, 2023 11:30 am
10 Oversold Penny Stocks To Buy
- Aug 14th, 2023 11:55 am
Vincerx Pharma (NASDAQ:VINC) Will Have To Spend Its Cash Wisely
- Aug 10th, 2023 1:09 pm
Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- Aug 7th, 2023 1:25 pm
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
- May 11th, 2023 8:05 pm
Vincerx Pharma Presents Preclinical Data on VIP924, a First-in-Class Antibody-Drug Conjugate (ADC), at the 2023 American Association for Cancer Research (AACR) Annual Meeting
- Apr 19th, 2023 1:05 pm
Vincerx Pharma Presents Preclinical Data on Novel Small Molecule Drug Conjugates at the American Association for Cancer Research (AACR) Annual Meeting 2023
- Apr 17th, 2023 5:35 pm
Vincerx Pharma Presents Preclinical Data on VIP236, a First-in-Class Small Molecule Drug Conjugate (SMDC), at the 2023 American Association for Cancer Research (AACR) Annual Meeting
- Apr 17th, 2023 12:00 pm
Scroll